Denise Dignam - Mar 3, 2025 Form 4 Insider Report for Chemours Co (CC)

Role
President & CEO, Director
Signature
/s/ Kristine Wellman, Attorney-in-Fact
Stock symbol
CC
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 08:48 PM
Previous filing
Mar 4, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Award $0 +106K +150.33% $0.00 177K Mar 3, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Award $0 +354K $0.00 354K Mar 3, 2025 Common Stock 354K $13.86 Direct F3
transaction CC Stock Option (Right to Buy) Award $0 +368K $0.00 368K Mar 3, 2025 Common Stock 368K $15.25 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2026.
F2 Includes directly owned shares, RSUs and dividend equivalent units.
F3 These options are scheduled to vest in three equal annual installments beginning on March 3, 2026.
F4 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.